Figure 2.
Rivaroxaban population PK modeling results for children with cancer-associated VTE in comparison with adult patients with VTE and children with VTE without cancer.6 od, once daily; PopPK, population PK.
Rivaroxaban population PK modeling results for children with cancer-associated VTE in comparison with adult patients with VTE and children with VTE without cancer.6 od, once daily; PopPK, population PK.
